Navigation Links
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
Date:12/20/2007

procedures; making MPI the most widely performed nuclear medicine scan in the US. Recent market research estimates indicate that existing MPI products generate revenues in excess of $800 million annually in the U.S. and that Sestamibi and tetrofosmin account for approximately 90% of all MPI procedures.

Cardiac Imaging with Tc-99m Sestamibi

The sestamibi kit is used in nuclear medicine imaging to show how well the heart muscle (myocardium) is supplied with blood (perfused) both at rest and during strenuous activity. The radioisotope Technetium-99m is attached to the sestamibi molecule forming Tc-99m Sestamibi. When injected into the bloodstream this radiopharmaceutical agent is distributed throughout the heart muscle in proportion to the blood flow received by various portions of the heart. Heart images are then obtained using a gamma camera that can detect the Technetium-99m. Two sets of images are typically taken, one while the patient is at rest and a second set while the patient is under stress, often by exercising on a treadmill or stationary bicycle. The resulting two sets of images are compared with each other to diagnose the presence of coronary heart disease by detecting areas of the heart that may not be receiving normal blood flow. This imaging technique is known as cardiac stress testing or myocardial perfusion imaging (MPI).

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose a
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
5. Mediware Names Thomas K. Mann Chief Executive Officer
6. Cleveland-based Health Care Tech Company Within3 Names New CEO
7. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
8. Patient Safety Authority Board of Directors Names Infection Advisory Panel
9. Hooper Holmes Names Chris Behling President of Health & Wellness Division
10. MDMA Names New Director of Federal Affairs
11. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 Each year, the Susan G. Komen ... and awareness for breast cancer. This year, Dr. Mark Deutsch ... as the entertainment sponsor for the 25th annual Susan G. ... at the Lenox Square Mall. , The Komen organization hopes ... raise $1.2 million. Perimeter Plastic Surgery has not only taken ...
(Date:5/4/2015)... May 04, 2015 TROY Healthcare Solutions ... North Atlantic Regional User Group (RUG) Conference in Baltimore, ... North Atlantic Regional User Group provides an opportunity for ... explore the exhibitor gallery. , In addition to sponsoring ... the Cerner North Atlantic RUG Conference. Attendees can stop ...
(Date:5/4/2015)... In May of 2010, after two years of ... the wake of this tragedy, Ty’s parents Kirk and Laura ... the grim reality of bullying and its devastating consequences. Stand ... Laura to share their story and offer education and tools ... family — a mission that took the Smalley family all ...
(Date:5/4/2015)... Washington, DC (PRWEB) May 04, 2015 ... of Kit Check as a finalist for the EY ... Washington Region. The awards program recognizes entrepreneurs who ... innovation, financial performance and personal commitment to their businesses ... finalist by a panel of independent judges. Award ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 New findings ... Brain Tumor Association (ABTA) show that people diagnosed with ... and treatment options, including clinical trials, at the time ... to make difficult decisions about their course of treatment. ... of the first nationwide brain tumor volunteer network, the ...
Breaking Medicine News(10 mins):Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3
... day in health-related lost productivity equals 56 cents per share ... 8 /PRNewswire/ -- In today,s challenging economy every ... for business success. To help companies make the business case ... a DVD about the experience of a Fortune 500 company ...
... Blue Cross and Blue Shield of Georgia,(BCBSGa) today announced ... more than 996 not-for-profit organizations in 2009 as part,of the ... of Georgia Foundation will match 50 percent of associate pledges,increasing ... "Every day our associates work to ...
... The end of fall marks an exciting time,for ... their,professional careers. Fellows from around the world will gather ... Interventions (SCAI),Third Annual Interventional Cardiology Fall Fellows Course in ... Given the aging population and the increasing number ...
... low risk of developing intractable disease , , MONDAY, Dec. ... giving anti-seizure medication to children with epilepsy who,ve achieved ... at high risk of later developing intractable epilepsy, a ... affects about 10 percent of children with epilepsy, is ...
... drug treatment, researchers note , , MONDAY, Dec. 8 (HealthDay ... genes of more than 40,000 people has identified 11 ... as LDL cholesterol and triglycerides. , "These locations point ... cholesterol in humans," said Dr. Sekar Kathiresan, director of ...
... Inc.,(Nasdaq: ARNA ) announced today that ... Monday, December 15, 2008, beginning at approximately 12:00 ... Jack Lief,President and Chief Executive Officer, Dominic P. ... and William R. Shanahan, M.D., Vice,President and Chief ...
Cached Medicine News:Health News:Integrated Benefits Institute Helps Employers Make the Business Case for Health and Productivity Improvement 2Health News:Blue Cross and Blue Shield of Georgia Associates Pledge More Than $1.3 Million to Community Organizations 2Health News:Blue Cross and Blue Shield of Georgia Associates Pledge More Than $1.3 Million to Community Organizations 3Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 2Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 3Health News:Seizure Meds Can Be Safely Withdrawn From Kids With Epilepsy 2Health News:11 New Cholesterol Genes Identified 2Health News:11 New Cholesterol Genes Identified 3Health News:Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008 2Health News:Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008 3
(Date:5/4/2015)... May 4, 2015 Southfield Capital, ... firm, announced today that it completed a ... Communications. BioPharm specializes in the development and multi-channel ... pharmaceutical and biotechnology industries. Through ... shareholders half of their invested capital and ...
(Date:5/4/2015)... PAREXEL International Corporation (NASDAQ: PRXL ) announced ... Conference on Monday, May 18, 2015, in New York City.  ... Officer will be making a presentation on PAREXEL and discussing ... webcast of the presentation will be available through the "Investors" ... Upcoming Events portion of the main page, and a replay ...
(Date:5/4/2015)... Calif. , May 4, 2015  Impax Laboratories, ... filled two key executive leadership roles, appointing  Donna M. ... Deborah M. Penza , as Senior Vice President, Chief ... report to Impax,s President and Chief Executive Officer, ... Donna and Deborah have joined the Impax team," said ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2PAREXEL International to Present at UBS Healthcare Conference 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... March 31, 2011 Virtual Radiologic (vRad), ... 2011 Stevie® Award for Sales & Customer Service. vRad® ... managed via the Internet, that provides secure access to ... team via mobile digital devices and the Internet. vRad ...
... WALTHAM, Mass., March 31, 2011 Syndax Pharmaceuticals, Inc., ... on entinostat, an oral, highly selective, class I histone ... Annual American Association for Cancer Research meeting April 2 ... "The breadth of exciting data being presented at AACR ...
Cached Medicine Technology:Virtual Radiologic Wins Stevie® Award for Improving Patient Care through Mobile Technology 2Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting 2Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting 3Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting 4